Trial Profile
Comparative Assessment of Clinical Efficacy of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jan 2016
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- 05 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 22 Jul 2011 Planned end date changed from 1 May 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.